Table 4 Influence of the endoscopic appearance of the major papilla on the success of NKF and adverse events in 361 patients
Type I n (%) 47 (13.0) | Type IIa n (%) 128 (35.5) | Type IIb n (%) 109 (30.2) | Type IIc n (%) 35 (9.6) | Type IIIa n (%) 14 (3.9) | Type IIIb n (%) 14 (3.9) | Type IV n (%) 14 (3.9) | p | |
|---|---|---|---|---|---|---|---|---|
Biliary cannulation, n (%) | ||||||||
Success in first ERCP | 44 (93.6) | 124 (96.9) | 100 (91.7) | 35 (100) | 9 (64.3) | 10 (71.4) | 12 (85.7) | 0.000 |
Overall biliary cannulation | 46 (97.9) | 127 (99.2) | 105 (96.3) | 35 (100) | 13 (92.9) | 12 (85.7) | 13 (92.9) | 0.041 |
Cannulation time (mins), median (p25–p75) | 14.3 (7–26) | 5.0 (1–38) | 8.8 (7–15) | 5.5 (3–12) | 8.0 (7–10) | 9.5 (5–14) | 8.7 (5–21) | 0.0001 |
Adverse events, n (%) | ||||||||
Overal | 5 (10.6) | 7 (5.5) | 10 (9.2) | 3 (8.6) | 0 | 2 (14.3) | 0 | 0.549 |
Pancreatitis | 4 (8.5) | 5 (3.9) | 5 (4.6) | 2 (5.7) | 0 | 2 (14.3) | 0 | 0.488 |
Bleeding | 1 (2.1) | 2 (1.6) | 5 (4.6) | 1 (2.9) | 0 | 0 | 0 | 0.837 |
Perforation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | – |